News

31 May 2019

IDIBELL, re-accredited as a health research institute by the Institute of Health Carlos III

The Bellvitge Biomedical Research Institute (IDIBELL) has been re-accredited this May by the Institute of Health Carlos III as a health research institute.

30 May 2019
  • Càncer
  • Medicina Regenerativa
  • Neurociències
  • Medicina Translacional

[call] IDIBELL Summer Training 2019

With the aim to encourage students to pursue a scientific career after graduation, the Bellvitge Biomedical Research Institute (IDIBELL) offers 10 undergraduate students in their final year of university and master students the opportunity to join the research groups at IDIBELL and complete their

29 May 2019
  • Medicina Translacional

SeptiLoop receives € 100,000 to develop a rapid diagnostic kit for sepsis

The IDIBELL and Bellvitge University Hospital researcher Joan Sabater, in collaboration with the Loop Dx start-up, of the Center for the Integration of Medicine and Innovative Technologies (CIMTI), has obtained € 100,000 of funding from the aid Product of the AGAUR agency of the Government of Cat

29 May 2019
  • Neurociències

Analyzing a protein from the cerebrospinal fluid will help diagnose and prevent clinical evolution of patients with prion diseases

  • This protein is found in neurons, and can be easily detected at the cerebrospinal fluid of alive patients
15 May 2019
  • Càncer

[Statement] Finalisation of IDIBELL's Epigenetics and Cancer Biology Program

The Bellvitge Biomedical Research Institute (IDIBELL) would like to state that, in accordance with the new responsibility of Dr Manel Esteller as director of the Josep Carreras Leukaemia Research Institute (IJC), the Cancer Epigenetics and Biology Program (PEBC) that he has led at IDIBELL so far